Back to Journals » Breast Cancer: Targets and Therapy » Volume 4

Potential of afatinib in the treatment of patients with HER2-positive breast cancer

Total article views   HTML views PDF downloads Totals
14,354 Dovepress* 12,634+ 3,138 15,772
PubMed Central* 1,720 1,448 3,168
Totals 14,354 4,586 18,940
*Since 27 August 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed and Google Scholar